Natura Hue Chem: Aditya Sharma completes independent director term
Natura Hue Chem Limited reported that Aditya Sharma’s term as Independent Director ended on June 29, 2026. He simultaneously stepped down from the Nomination and Remuneration Committee. The filing notes he holds no shares in the entity.

*this image is generated using AI for illustrative purposes only.
Natura Hue Chem Limited has intimated that Mr. Aditya Sharma completed his tenure as an Independent Director with effect from the end of the day on June 29, 2026.
Upon the completion of his term, Mr. Sharma also ceased to hold the position of Member of the Nomination and Remuneration Committee. The company made this disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
Board Composition Changes
The departure marks the conclusion of Mr. Sharma’s non-executive independent director role. The filing confirms that he holds nil shares in the company. No specific reason other than the completion of tenure was cited for the change in board composition.
Key Details
| Detail | Information |
|---|---|
| Director Name | Aditya Sharma |
| DIN | 08718848 |
| Date of Cessation | June 29, 2026 |
| Reason | Completion of Tenure |
| Shares Held | Nil |
The Company Secretary and Compliance Officer, Komal Goyal, signed the intimation to the Bombay Stock Exchange on August 12, 2026.
Historical Stock Returns for Natura Hue Chem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.95% | -0.31% | +0.40% | +193.08% | +305.77% | +3,037.50% |
Has Natura Hue Chem initiated the search process for a new Independent Director to replace Mr. Sharma, and what is the expected timeline for appointment?
How will the vacancy on the Nomination and Remuneration Committee impact the company's ability to schedule upcoming board meetings or approve executive compensation?
Are there any pending strategic decisions or regulatory filings that might be delayed due to the temporary reduction in board strength?
































